Target Name: WNT1
NCBI ID: G7471
Review Report on WNT1 Target / Biomarker Content of Review Report on WNT1 Target / Biomarker
WNT1
Other Name(s): Wnt family member 1 | WNT1_HUMAN | INT1 | BMND16 | OI15 | Proto-oncogene Int-1 homolog | wingless-type MMTV integration site family member 1 | proto-oncogene Int-1 homolog | wingless-type MMTV integration site family, member 1 (oncogene INT1) | Wingless-type MMTV integration site family, member 1 | Wnt-1 | Proto-oncogene Wnt-1

WNT1: A Key Regulator of Cell Proliferation and Tissue Development

WNT1 (Wnt family member 1) is a transmembrane protein that is expressed in various tissues throughout the body. It is a key regulator of cell proliferation and is involved in the development and maintenance of many different tissues, including neural, epithelial, and pluripotent stem cells. WNT1 has also been implicated in a number of diseases, including cancer, neurodegenerative diseases, and developmental disorders. As a drug target or biomarker, WNT1 is of great interest to researchers because of its potential to contribute to the development of new treatments for a variety of diseases.

The Wnt family of proteins is characterized by a conserved catalytic core and a transmembrane region. The transmembrane region of WNT1 consists of a unique arrangement of transmembrane domains that give the protein its unique structure and its ability to interact with various signaling molecules. WNT1 has four transmembrane domains: a N-terminal transmembrane domain, a middle transmembrane domain, a C-terminal transmembrane domain, and an optional C-terminal secretory domain.

The N-terminal transmembrane domain of WNT1 is a critical region that is involved in the formation of the protein's Membranous organization. This domain is responsible for the formation of the protein's Membranous organization, which is a structure that is involved in the regulation of cell signaling pathways. The middle transmembrane domain of WNT1 is a region that is involved in the regulation of cell adhesion and in the development of tissues. This domain is also involved in the regulation of cell signaling pathways and is thought to play a role in the development of various diseases, including cancer.

The C-terminal transmembrane domain of WNT1 is a region that is involved in the regulation of cell proliferation and in the development of tissues. This domain is also involved in the regulation of cell signaling pathways and is thought to play a role in the development of various diseases, including cancer. The optional C-terminal secretory domain of WNT1 is a region that is responsible for the production and release of the protein. This domain is not involved in the regulation of cell signaling pathways or the development of tissues, but is instead involved in the regulation of cell adhesion and in the production and release of the protein.

WNT1 has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and developmental disorders. For example, studies have shown that high levels of WNT1 are associated with the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. Additionally, WNT1 has been shown to be involved in the regulation of cell proliferation, which is thought to play a role in the development of cancer.

As a drug target or biomarker, WNT1 is of great interest to researchers because of its potential to contribute to the development of new treatments for a variety of diseases. For example, studies have shown that inhibiting the activity of WNT1 has the potential to be a effective treatment for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. Additionally, because WNT1 is involved in the regulation of cell proliferation, inhibiting its activity has the potential to be an effective treatment for cancer.

In conclusion, WNT1 is a transmembrane protein that is involved in the development and maintenance of many different tissues. It is also implicated in a number of diseases, including cancer and neurodegenerative diseases. As a drug target or biomarker, WNT1 is of great interest to researchers because of its potential to contribute to the development of new treatments for a variety of diseases. Further research is needed to fully understand the role of WNT1 in

Protein Name: Wnt Family Member 1

Functions: Ligand for members of the frizzled family of seven transmembrane receptors (Probable). Acts in the canonical Wnt signaling pathway by promoting beta-catenin-dependent transcriptional activation (PubMed:23499309, PubMed:26902720, PubMed:28528193, PubMed:23656646). In some developmental processes, is also a ligand for the coreceptor RYK, thus triggering Wnt signaling (By similarity). Plays an essential role in the development of the embryonic brain and central nervous system (CNS) (By similarity). Has a role in osteoblast function, bone development and bone homeostasis (PubMed:23499309, PubMed:23656646)

The "WNT1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about WNT1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

WNT10A | WNT10B | WNT11 | WNT16 | WNT2 | WNT2B | WNT3 | WNT3A | WNT4 | WNT5A | WNT5B | WNT6 | WNT7A | WNT7B | WNT8A | WNT8B | WNT9A | WNT9B | WRAP53 | WRAP73 | WRN | WRNIP1 | WSB1 | WSB2 | WSCD1 | WSCD2 | WSPAR | WT1 | WT1-AS | WTAP | WTAPP1 | WTIP | WWC1 | WWC2 | WWC2-AS2 | WWC3 | WWOX | WWP1 | WWP2 | WWTR1 | WWTR1-AS1 | XAB2 | XACT | XAF1 | XAGE-4 | XAGE1A | XAGE1B | XAGE1D | XAGE2 | XAGE3 | XAGE5 | XBP1 | XCL1 | XCL2 | XCR1 | XDH | XG | XGY2 | XIAP | XIRP1 | XIRP2 | XIST | XK | XKR3 | XKR4 | XKR5 | XKR6 | XKR7 | XKR8 | XKR9 | XKRX | XKRY | XKRYP7 | XLOC_007697 | XLOC_008559 | XLOC_009911 | XNDC1N | XPA | XPC | XPC complex | XPNPEP1 | XPNPEP2 | XPNPEP3 | XPO1 | XPO4 | XPO5 | XPO6 | XPO7 | XPOT | XPR1 | XRCC1 | XRCC2 | XRCC3 | XRCC4 | XRCC5 | XRCC6 | XRCC6P5 | XRN1 | XRN2 | XRRA1